Patent for Humanity Award to:
Intermark Partners Strategic Management for ‘NutraIso Nutrient Extraction Technology’
Award Recipient: Dr. Glenn H. Sullivan
Award Presentation: U.S. Senator Patrick Leahy and
U.S. Department of Commerce Undersecretary Teresa Stanek Rea
The NutraIso technology embodies a unique multiphase process that utilizes specific enzyme combinations under precise time and temperature conditions to optimally extract the bioactive phytonutrient isolates from rice bran and other cereal grains. This method achieves a significantly enhanced protein, carbohydrate, micronutrient and antioxidant complex, thereby increasing the overall nutritional values of the derivative as a functional/medical food ingredient for nutritional supplementation in chronically malnourished populations worldwide.
Rice bran is a by-product of the rice milling process and is exceptionally high in natural phytonutrients which have been scientifically documented to have potentially significant health benefits when properly extracted, isolated and concentrated, thereby providing a sustainable and low-cost nutritional ingredient for meeting the needs of undernourished populations in nutrient deficit regions. Rice is the most widely produced cereal grain worldwide, with nearly 40 million tons of rice bran available annually for human nutrition.
What was lacking in prior attempts to develop a commercially viable extraction process is that such attempts produced derivatives that were not competitive in their nutritional profiles when compared to commercially available substitutes like whole milk, whey, and soy protein. Yet rice bran itself possesses a nutritional profile superior to these alternatives. The problem is that raw rice bran itself is not available for human consumption due to rapid enzyme oxidation activity that renders it to livestock feed. The NutraIso technology overcomes this problem through strategically integrated enzyme, time and temperature regimes that result in a commercially viable and nutrient-rich bioavailable extract for human consumption. It is this nutrient-rich extract that is being formulated into supplements for pregnant mothers, lactating mothers and infants up to thirty-six months of age; a time when an infants physical, mental and metabolic processes are largely developed, and a life-stage when chronic malnutrition can be remediated.
The NutraIso formulations are currently being administered in Guatemala for a collaborative program with the Government of Guatemala to eradicate chronic malnutrition at an early stage in the life of infants, thereby enhancing the overall physical and socioeconomic well being of the population and reducing food welfare costs at the national level over time.
For additional information, email firstname.lastname@example.org